Cervical cancer is the fourth most common cancer among women globally, with nearly all cases attributed to human papillomavirus (HPV). According to the World Health Organization (WHO, 2016), over 500,000
new cases of cervical cancer and more than 250,000 deaths occur annually worldwide. More recent data indicates 570,000 new cases nand 311,000 deaths across various regions globally. Amoo et al. (2018)
highlighted that 80% of cervical cancer cases occur in low-income countries, where access to screening and preventive services is severely limited. Additionally, studies have shown that out of 78,897 women
diagnosed with cervical cancer annually in Africa, 61,671 succumb to the disease. This indicates that African women face a cancer mortality rate twice as high as their counterparts in developed countries.The